Join live Dr. Martin Lange and Dr. Carlo Stresemann on a short journey into the oncology and translational research services at NUVISAN-ICB.
With a focus on oncology research, we will explain how to overcome potential challenges in your drug discovery programs.
By showcasing some real-life examples, we will discuss how to identify combination partners to extend the clinical indication space, how to use chemical probes for target validation and how to identify biomarkers for patient selection and as pharmacodynamic read-outs.
In a Q&A session following the presentation, it will be possible to discuss further on these or any other topics of interest.
Interested in learning how to accelerate your drug discovery program in oncology and lower your attrition rate?
In this 45-minute presentation, Dr. Martin Lange, Head of Translational Research, and Dr. Carlo Stresemann, Head of Therapeutic Oncology Research, will cover:
• Our services at NUVISAN-ICB
• Finding the right drug combination partner
• Chemical probe-based target validation
• Biomarkers for patient selection and pharmacodynamic read-outs
• Live Q&A Session
